LOXL3 and melanoma: Gain- and loss-of-function studies revealed that LOXL3 contributed to melanomagenesis, protected genome integrity of melanoma cells and physically interacted with other proteins involved in genome integrity maintenance, such as BRCA2 and DNA mismatch repair protein MSH2.